 | | | | |
| |  | |  | | |
| |
 |
| PRIME NEWS | |
|
 |
|
|
Japan, China, and Australia have ranked top in the Nature Asia-Pacific Publishing Index, a website which measures the annual output of research articles in Nature-branded journals from countries and institutions in the Asia-Pacific region
|
|
|
|
|
|
|
|
|
The Australian oncology markets high value and growth opportunities have made it an attractive arena for drug developers to enter. Top 20 cancer therapy brands sales totaled $545 mn in Australia in 2008, growing at a CAGR of 30% since 2005
|
|
|
|
|
|
|
| | |  | |  | | |
|
|
 |
|
 |
|
|
|
 |
NEWS |
 |
|
|
|
Acurex collaborates with Eli Lilly for Axiron
|
|
| Eli Lilly and Acrux have entered into an exclusive worldwide license agreement for the potential commercialization of Acruxs experimental underarm testosterone solution (proposed trade name Axiron) |
|
|
|
|
|
Lilly to acquire global license to AXIRON from Acrux
|
|
| Eli Lilly and Company, and Acrux, an Australian drug delivery company, have entered into an exclusive worldwide license agreement for the potential commercialization of Acrux' experimental underarm testosterone solution |
|
|
|
|
|
|
 |
|
 |
|
|
|
|
|
|
|
|
|
|
FEATURES |
|
|
|
|
|
|
Australia, biotech's destination next
|
|
| Located in the southern hemisphere, Australia, officially known as the Commonwealth of Australia, is striving to become the well-established destination for biotechnology. Its government has a vision to become one of the top five global locations |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
R & D |
|
|
|
|
|
|
Ondek starts first human trial of life saving oral vaccines
|
|
| Ondek, an Australian biotechnology company, founded by Prof Barry Marshall, an Australian who won a Nobel Prize for discovering the bacteria that causes stomach ulcers has launched the first human clinical trial to see if the same bugs can be used |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
POLICIES |
|
|
|
|
Mesoblast gets US patent for bone repair products
|
|
| Australia's regenerative medicine company, Mesoblast said that the US Patent and Trademark Office has granted a key patent that provides exclusive commercial protection for its bone tissue generating products in the US |
|
|
|
|
|
DispersinB gets Australian patent
|
|
| Kane Biotech, a biotechnology company developing products that prevent and disperse microbial biofilms, has received patent No. 2003284385 entitled Compositions and methods for enzymatic detachment of bacterial and fungal biofilms by IP Australia |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|  | |  | | | | |  | |  |
|
|
|
| | | | | | | | |
